Clinical trial · Interventional
Cancer of the Upper Aero-digestive Tract and Socio-professional Future
NCT01788878CI-TRIAL-00023235CARDELunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to explore the main factors associated with the return to work of patients presenting an upper aero-digestive tract cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Upper Aerodigestive Tract Neoplasms | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Questionnaires | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Questionnaires
- description
- completion of questionnaires
- interventionNames
- Behavioral: Questionnaires
Primary outcomes (1)
- measure
- Main psycho-medical and socio-professional determinants associated with return to work at 18 months after diagnosis
- timeFrame
- At month 18
Secondary outcomes (5)
- measure
- Period until return to work (also part-time work)
- timeFrame
- At month 6, month 12, month 18
- measure
- Modalities, period and stability of this return to work
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * Age at diagnosis ≥ 18 to ≤ 55 years * Employed at the entry into the care pathway * Presenting an upper aero-digestive tract cancer (excluding nasal cavities), stage I, II and III, under a first anti-tumor treatment (surgery, radiotherapy, or chemotherapy) * Patient mastering the French language * Affiliated to the social security system * Consent signed by the patient before the implementation of any specific study procedure Exclusion Criteria: * Having been treated for another cancer before (except skin cancer and / or prostate) * Metastatic disease from the outset * Patient unable to submit to a regular follow-up * Presenting psychiatric disorders
References
Publications (0)
Data not yet available
No reference posted for this study.